Anna Wilhoit
Psychiatric/Mental Health · Corbin, KYNPI 1104366285
Payments from drug & device makers
Across 245 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$882
- Vanda Pharmaceuticals Inc.$648
- Johnson & Johnson$430
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$365
- Lundbeck LLC$295
- plus $1K from 12 others
What the payments were for
- Food & beverage$5,12199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 55 | $1,122 |
| AbbVie | 44 | $882 |
| Vanda Pharmaceuticals Inc. | 27 | $648 |
| Johnson & Johnson | 13 | $430 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $365 |
| Lundbeck LLC | 21 | $295 |
| Axsome Therapeutics, Inc. | 13 | $288 |
| E.r. Squibb & Sons, L.L.C. | 10 | $270 |
| Alkermes, Inc. | 9 | $172 |
| Ironshore Pharmaceuticals Inc. | 8 | $161 |
| Biogen | 6 | $123 |
| Almatica Pharma LLC | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $99 |
| Supernus Pharmaceuticals, Inc. | 5 | $79 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Neurocrine Biosciences, Inc. | 2 | $28 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,168 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 42 | $60,882 |
| TrintellixVortioxetine Hydrobromide | 12 | $9,726 |
| Vilazodone Hcl | 23 | $2,758 |
| Quetiapine Fumarate | 186 | $1,244 |
| Hydroxyzine Hcl | 77 | $958 |
| Buspirone Hcl | 70 | $829 |
| Duloxetine Hcl | 46 | $809 |
| Mirtazapine | 45 | $405 |
| Clonazepam | 90 | $308 |
| Bupropion Hcl SrBupropion Hcl | 26 | $251 |
| Sertraline Hcl | 55 | $250 |
| Lamotrigine | 45 | $244 |
| Fluoxetine Hcl | 67 | $234 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $207 |
| Escitalopram Oxalate | 72 | $205 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $882 | $60,88242 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $99 | $9,72612 claims |
| Almatica Pharma LLCSertraline Hcl | $100 | $25055 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Corbin
- Timothy CouchCorbin$20K
- Holly SteelyCorbin$7K
- Josephine OwensCorbin$7K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Denise de AngelisLouisville$384K
- Jennifer SampangCrestview Hills$322K
- Jeremy FisherSouth Shore$197K
- Jessica EstesLewisport$175K
- Christopher MulloneyNancy$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.